PTHS
PTHS
US1711262048
Pelthos Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
78.48M EUR
105.09M EUR
70.8M EUR
100.27M EUR
Enterprise Value
127.4M EUR
154.01M EUR
65.4M EUR
117.12M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.61x
--
--
--
Price to Sales
1.81x
2.43x
2.56x
5.97x
Price to Book
--
--
2.02x
2.58x
EV/Revenue
2.94x
3.56x
2.36x
6.97x
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-46.6%
-48.05%
-61.12%
-29.88%
ende